Diagnostics; making a difference

Recent Blogs

The British In Vitro Diagnostics Association (BIVDA) is the national industry association for companies with major involvement and interest in the in vitro diagnostics (IVD) industry. BIVDA represents both manufacturers and distributors who are active in the UK. It is not just an association of UK diagnostic companies; all IVD companies, irrespective of their national origin, are eligible to become members of BIVDA.

As well as providing a range of support services for its members, BIVDA pursues a strategy of raising the awareness of the clinical and cost utility of diagnostics in the provision of effective healthcare in the UK. Our
Code of Conduct governing members business practice is an integral part of the association.


BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer
Cervical cancer screening samples to be tested for HPV first
BIVDA publishes report looking at the point of care testing environment in the UK
Government approves UK NSC's recommendation regarding the bowel cancer screening programme in England
BIVDA's response to the final recommendations of the Review on AMR
Discovery Awards launched to help teams progress ideas for the Longitude Prize
Supporting evidence published for the Accelerated Access Review
Final report of Carter Review published
Simon Stevens launches NHS Innovation ‘Test Beds’
BIVDA joins declaration by industry on combating antimicrobial resistance
BIVDA launches vision for increasing access to molecular diagnostics
Chris Wormald appointed as the new Permanent Secretary at the Department of Health
UK National Screening Committee publishes 11 recommendations
Two new NHS Genomic Medicine Centres join the 100,000 Genomes Project
BIVDA’s Response to the Spending Review and Autumn Statement
Public Health England publish second annual report on antibiotic resistance surveillance
All Party Parliamentary Group for Life Sciences supports funding calls ahead of the Comprehensive Spending Review 
Science and Technology Committee calls for increase in science funding
The Accelerated Access Review publishes its interim report

Precision Medicine Catapult announces initial six centres of excellence



See all BIVDA and sector news

The importance of IVDs in tackling the AMR challenge

click on picture for larger version

Map showing how CRP testing is reducing the use of antibiotics in Europe
Adapted from ‘Straight to the Point’ June 2015

Rapid diagnostics would reduce unnecessary prescription
‘Review on Antimicrobial Resistance.’

If not tackled, rising AMR could have a devastating impact 
‘Review on Antimicrobial Resistance.’

BIVDA dates

7 Sept - Digital Pathology WP
8 Sept - Executive Committee Meeting
8 Sept - C-suite Briefing on Impact of the IVD Regulation & of the Genereal Data Protection Regulation.
9 Sept - Regulatory Affairs WP
13 Sept - Diabetes WP
14 Sept - Procurement WP
22 Sept - Point of Care WP
6 Oct. - Precision Diagnostics WP
1-2 Nov - Regulatory Affairs Seminar  - Save the Date

Click here to find out more about our Events

Twitter Feed

Useful Links

For information on laboratory medicine and diagnostic tests

BIVDA is not responsible for the content of external internet/web sites

IVD Australia
Lab Tests Online UK
Labs are Vital
Medical Lab Org